UK dividends calendar - next 7 days
21st Feb 2025 12:36
| Price | $0.864 on 27-02-2025 at 17:30:00 |
|---|---|
| Change | $0.00 0% |
| Buy | $0.866 |
| Sell | $0.864 |
| Buy / Sell BPCR Shares | |
| Last Trade: | Buy 428,349.00 at $0.864 |
| Day's Volume: | 2,244,968 |
| Last Close: | $0.864 |
| Open: | $0.866 |
| ISIN: | GB00BDGKMY29 |
| Day's Range | $0.864 - $0.868 |
| 52wk Range: | $0.83 - $0.94 |
| Market Capitalisation: | $1,015m |
| VWAP: | $0.867039 |
| Shares in Issue: | 1,175m |
Sector: Closed End Investments
Biopharma Cred. (BPCR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 428,349 | $0.864 | Suspected BUY Trade |
16:35:06 - 27-Feb-25 |
| Buy* | 500 | $0.866 | Automatic Execution |
16:25:38 - 27-Feb-25 |
| Unknown* | 7,234 | $0.868126 | Ordinary Currency Conversion |
16:22:44 - 27-Feb-25 |
| Buy* | 7,970 | $0.866 | Automatic Execution |
16:20:24 - 27-Feb-25 |
| Buy* | 1 | $0.866 | Automatic Execution |
16:20:24 - 27-Feb-25 |
| Sell* | 15 | $0.862 | SI Trade |
16:19:57 - 27-Feb-25 |
| Buy* | 4 | $0.866 | Automatic Execution |
16:19:37 - 27-Feb-25 |
| Unknown* | 11,633 | $0.866 | Automatic Execution |
16:19:28 - 27-Feb-25 |
| Buy* | 12,613 | $0.866 | Automatic Execution |
16:19:28 - 27-Feb-25 |
| Sell* | 41,019 | $0.866 | Automatic Execution |
16:19:28 - 27-Feb-25 |
Biopharma Cred. (BPCR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Feb 2025 6:15 pm | RNS | Transaction in Own Shares |
| 26th Feb 2025 6:15 pm | RNS | Transaction in Own Shares |
| 25th Feb 2025 6:15 pm | RNS | Transaction in Own Shares |
| 21st Feb 2025 4:00 pm | RNS | Net Asset Value(s) and Monthly Factsheet |
| 20th Feb 2025 7:00 am | RNS | Notice of Full Year Results |
| 18th Feb 2025 6:15 pm | RNS | Transaction in Own Shares |
| 12th Feb 2025 6:15 pm | RNS | Transaction in Own Shares |
| 11th Feb 2025 6:15 pm | RNS | Transaction in Own Shares |
| 10th Feb 2025 6:15 pm | RNS | Transaction in Own Shares |
| 6th Feb 2025 6:15 pm | RNS | Transaction in Own Shares |